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Abstract
Background: The isothiocyanate sulforaphane (SFN) possesses interesting anticancer activities. However, recent studies
reported that SFN promotes the formation of reactive oxygen species (ROS) as well as DNA breakage.
Methodology/Principal Findings: We investigated whether SFN is able to damage RNA, whose loss of integrity was
demonstrated in different chronic diseases. Considering the ability of SFN to protect from genotoxicity, we also examined
whether SFN is able to protect from RNA damage induced by different chemicals (doxorubicin, spermine, S-nitroso-N-
acetylpenicillamine, H2O2). We observed that SFN was devoid of either RNA damaging and RNA protective activity in human
leukemic cells. It was able to potentiate the RNA damage by doxorubicin and spermine. In the first case, the effect was
attributable to its ability of modulating the bioreductive activation of doxorubicin. For spermine, the effects were mainly
due to its modulation of ROS levels produced by spermine metabolism. As to the cytotoxic relevance of the RNA damage,
we found that the treatment of cells with a mixture of spermine or doxorubicin plus SFN increased their proapoptotic
potential. Thus it is conceivable that the presence of RNA damage might concur to the overall toxic response induced by a
chemical agent in targeted cells.
Conclusions/Significance: Since RNA is emerging as a potential target for anticancer drugs, its ability to enhance spermine-
and doxorubicin-induced RNA damage and cytotoxicity could represent an additional mechanism for the potentiating
effects of SFN associated with anticancer drugs.
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Introduction
Broccoli and broccoli sprouts contain wide amounts of
glucosinolates [1]. Numerous studies have demonstrated the
chemopreventive effect of increasing cruciferous vegetable intake
against cancer, which is mainly imputable to the activity of various
isothiocyanates, highly biologically active compounds formed
upon enzymatic hydrolysis of glucosinolates [2]. Sulforaphane
[SFN, 1-isothiocyanato-4-(methyl-sulfinyl)-butane; CH3-SO-
(CH2)4-N C S], a well characterized isothiocyanate compound,
was found to be obtained from glucoraphanin, a major
glucosinolate in broccoli/broccoli sprouts [3]. The chemopreven-
tive properties of SFN against cancer are through both ‘‘blocking’’
and ‘‘suppressing’’ effects [2]. The blocking function of SFN is
achieved through inducing phase 2 detoxification enzymes that
promote excretion of carcinogens [2]. Subsequent studies revealed
the suppressing effects of SFN mediated by its pleiotropic capacity
to simultaneously modulate multiple cellular targets involved in
cell proliferation and apoptosis [4]. The ability of SFN to induce
apoptosis and cell-cycle arrest is associated with regulation of
many molecules including Bcl-2 family proteins, p53, caspases,
p21, cyclins, and cyclin-dependent kinases [4]. SFN was also
shown to suppress angiogenesis and metastasis by the downreg-
ulation of vascular endothelial growth factor, HIF-1a, matrix
metalloproteinase-2 and matrix metalloproteinase-9 [4].
Genomic DNA breaks represent an important trigger of
apoptosis [5]. Accumulating evidence has shown that SFN
increases intracellular reactive oxygen species (ROS) levels and
induces apoptosis in various cancer cell lines [6–8]. Although the
antitumorigenic effect of SFN is well established, a recent study
demonstrated that SFN promoted intracellular ROS formation as
well as DNA breakage in two different cell types [9]. The
formation of DNA single strand breaks was clearly demonstrated
in cells exposed to supranutritional concentrations of SFN. On the
contrary, no sign of DNA lesions or micronuclei induction could
be observed at the nutritionally attainable concentrations of SFR
(#10 mM) [9,10].
In the present study, we performed our investigation to see
whether SFN is able to target and damage RNA. We used
nutritional and supranutritional concentrations of SFN.
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for different reasons. RNA is indeed mostly single-stranded and its
bases are neither protected by hydrogen bonding nor located
inside the double helix [11]. Almost all of the cellular RNA has
functional capacity for protein synthesis, whereas only 5% of the
transcribed sequences of genomic DNA encode proteins [12].
Finally, RNA is more abundant than DNA. In this view, it is
highly probable that significant damage to RNA occurs when cells
are exposed to nucleic acids damaging agents.
Despite its potential to affect cell physiology, potential triggers of
RNA damage as well as its pathophysiological implications remain
largely unknown. A significant loss of RNA integrity has been
demonstrated in advanced human atherosclerotic plaques [13,14].
Oxidative RNA damage has been described in several neurode-
generative diseases including Alzheimer disease, Parkinson disease,
dementia with Lewy bodies, and prion diseases [15–17]. Thus,
further studies on RNA damage and its surveillance may have a
significant impact on the understanding of the pathophysiology of
currently unresolved complex diseases.
Taking into account the demonstrated ability of SFN to protect
cells from genotoxic insult [18,19], we also investigated whether
SFN is able to protect cells from RNA damage induced by
different chemicals and its mechanism of action.
Methods
Ethics Statement
Blood donors provided written, informed consent for the study
use of the samples at the time of donation. The described study
was approved by the Comitato Etico dell’Azienda Unita ` Sanitaria
Locale di Bologna.
Chemicals
Reagent grade chemicals were purchased from Sigma (St.
Louis, MO, USA). SFN (Sigma) was dissolved in DMSO. The
stock solution (50 mM) of S-nitroso-N-acetylpenicillamine (SNAP)
was prepared by combining equal volumes of N-acetyl-D-
penicillamine (19 mg/mL in 100% ethanol) and NaNO2 (7 mg/
mL in RNase free water). The mixture was acidified with 50 mLo f
hydrochloric acid (19% v/v) per 1 mL of SNAP solution and
incubated for at least 30 min at 4uC before use. The stock solution
was prepared immediately before administration.
Lymphocyte isolation
Human peripheral blood (60 mL) was obtained from normal
healthy volunteers of AVIS (Italian Association of Voluntary Blood
Donors). Human mononuclear cells were isolated by density
gradient centrifugation using Histopaque-1077 (Sigma). Lympho-
cytes at a concentration of 4610
5 cells/mL were added with
10 mg/mL of phytohemagglutinin (Sigma).
Cell culture
Human leukemia Jurkat (acute T lymphoblastic leukemia) and
HL-60 (acute promyelocytic leukemia) cell lines were purchased
from Istituto Zooprofilattico Sperimentale Lombardia ed Emilia
Romagna, Brescia, Italy). KU812F (chronic myeloblastic leuke-
mia) cell line was purchased from LGC Standards (Sesto S.
Giovanni, Italy). Jurkat, HL-60, KU812F cell lines and non-
transformed human T lymphocytes were grown in suspension and
propagated in RPMI 1640 supplemented with 10% (Jurkat,
KU812F, T lymphocytes) or 20% (HL-60) heat-inactivated bovine
serum, 1% antibiotics (all obtained from Sigma). To maintain
exponential growth, the cultures were divided every third day by
dilution to a concentration of 1610
5 cells/mL.
Cell treatments
Cells were treated with different concentrations of SFN (0–
30 mM) for 6 or 24 h at 37uC. The RNA-damaging compounds
used in this study were SNAP, spermine NONOate, doxorubicin,
and H2O2 (all obtained from Sigma). Cells were treated with
different concentrations (0.0–0.5 mM) of SNAP, spermine NON-
Oate, or doxorubicin for 24 h at 37uC. An additional time point
(6 h) was included for spermine. For H2O2, the protocol was
slightly modified. The cultures were treated with different
concentrations of H2O2 (0.0–0.5 mM) in PBS for 6 h at 37uC.
The range of concentrations of the potential RNA-damaging
agents were selected considering the quantity of total RNA
extracted per cell, as recently suggested [14,20,21].
For assessing the potential protective activity of SFN, two
different treatment protocols were used:
– Pre-treatment protocol: the cells were incubated for 24 h with
SFN, then were washed and treated with the RNA toxic
compounds for 24 h (6 h for H2O2).
– Co-treatment protocol: the cultures were incubated for 24 h
with SFN and the RNA toxic compounds (6 h for H2O2).
The same experimental protocols were used in cell-free systems,
where RNA was extracted and then treated with the different
compounds in RNase-free water, and in HL-60, KU812F and
normal human T cells.
Cell viability
Viability was determined immediately after treatments by using
an EasyCyte 5HT flow cytometer (Millipore, Guava Technologies,
Hayward, CA, USA), according to the manufacturer’s recom-
mendations. Briefly, cells were mixed with an adequate volume of
Guava ViaCount Reagent (Millipore) and allowed to stain for at
least 5 min at room temperature. The Guava ViaCount Reagent
provides absolute cell count and viability data based on the
differential permeability of DNA-binding dyes and the analysis of
forward scatter. The fluorescence of each dye is resolved
operationally to allow the quantitative assessment of both viable
and non-viable cells present in a suspension.
Extraction of RNA
After cell treatment, RNA was isolated with an Agilent Total
RNA isolation Mini Kit (Agilent Technologies, Palo Alto, CA,
USA), according to the manufacturer’s recommendations. Con-
sidering the high susceptibility of RNA to RNase, all the steps were
performed by using nuclease-free water, RNase-free final collec-
tion tubes and RNase inhibitors. Briefly, 350–400 mL of lysis
solution were added to cell pellet and the cell homogenate was
centrifuged through a mini-prefiltration column. The flow-through
was mixed with an equal volume of 70% ethanol, incubated for
5 min at room temperature and centrifuged through a mini-
isolation column. The flow-through was discarded and the RNA-
loaded column was transferred into an RNase-free final collection
tube. Then, the purified RNA was eluted by addition of 10 mLo f
nuclease-free water.
Analysis of RNA damage
RNA analysis was performed by microfluidic capillary electro-
phoresis with the Agilent 2100 bioanalyzer. Tiny amounts of RNA
samples are separated in the channels of the microfabricated chips
according to their molecular weight and subsequently detected via
laser-induced fluorescence detection. The result is visualized as an
electropherogram where the amount of measured fluorescence
correlates with the amount of RNA of a given size. A software
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(RIN). The RIN algorithm is based on a selection of informative
features from the electropherograms. For this purpose, each
electropherogram is divided into the following nine adjacent
segments covering the entire electropherogram: a pre-region, a
marker-region, a 5S-region, a fast-region, an 18S-region, an inter-
region, a 28S-region, a precursor-region, and a post-region. In
addition, several global features are extracted, i.e. features that
span several segments. Among these, the average and maximum
height, areas and their ratios, total RNA ratio and the 28S area
ratio are the most important. The gradual degradation of RNA is
reflected by a continuous shift towards shorter fragment sizes. For
classification of RNA integrity, ten categories are defined from 0
(totally degraded RNA) to 10 (fully intact RNA) [22].
ROS detection
29,79-dichlorofluorescein-diacetate (DCFH-DA) was used for
ROS detection. DCFH-DA is cleaved intracellularly by nonspe-
cific esterases to form 29,79-dichlorodihydrofluorescein (DCFH),
which is further oxidized by ROS to form the highly fluorescent
compound 29,79-dichlorodihydrofluorescein (DCF) [23]. Briefly,
1.5610
6 cells were pre-treated with SFN 10 mM for 3 or 24 h.
Then, samples were washed, treated with spermine 0.5 mM and
additionally incubated for 3 or 24 h. At the end of the treatment,
the samples were washed and 0.5610
6 cells were stained with
DCHF-DA 5 mM. After 20 min of incubation at 37uC, fluores-
cence intensity was monitored at 510 nm using VICTOR 3 V
Multilabel Counter (PerkinElmer, Waltham, MA, USA). Data
were expressed as percentage of the control (untreated cells).
Measurement of thioredoxin reductase activity
The thioredoxin reductase activity was determined by the
colorimetric assay based on the reduction of 5,59-dithiobis(2-
nitrobenzoic) acid (DTNB) with NADPH to 5-thio-2-nitrobenzoic
acid (TNB), which produces a strong yellow color that is measured
at 412 nm by VICTOR 3 V Multilabel Counter (PerkinElmer).
Briefly, 1.5610
6 cells were treated with SFN 10 mM for 3 h or
24 h. In order to determine the DTNB reduction due only to the
thioredoxin reductase activity present in the samples, two assays
were performed. The first assay measured the total DTNB
reduction by the sample and the second one measured the DTNB
reduction by the sample in the presence of the thioredoxin
reductase inhibitor solution (Sigma). The difference between the
two analyses represents the DTNB reduction due to thioredoxin
reductase activity alone. The results were expressed in U/mL and
normalized to protein concentration determined by Bradford
reagent (Sigma). Thioredoxin reductase (Sigma) was used as
positive control.
Analysis of GSH levels
The level of total glutathione [i.e. glutathione (GSH) and
glutathione disulfide (GSSG)] was measured by the Gluthatione
Assay Kit (Sigma), in which catalytic amounts (nmoles) of GSH
caused a continuous reduction of DTNB to TNB, spectrophoto-
metrically measured at 412 nm by VICTOR 3 V Multilabel
Counter (PerkinElmer). The GSSG formed is recycled by
glutathione reductase and NADPH. The rate of TNB production
is proportional to the concentration of glutathione within the
sample. Briefly, 1.5610
6 cells were pre-treated with SFN 10 mM
for 3 h or 24 h. Then, samples were washed and treated with
spermine 0.5 mM for additionally 3 h. At the end of the
treatment, the samples were first deproteinized with a 5% 5-
sulfosalicylic acid solution (Sigma), centrifuged to remove the
precipitated protein and then assayed for total glutathione. The
results were expressed as glutathione concentration (mM).
Detection of apoptosis by flow cytometry
Flow cytometric procedures were performed with an EasyCyte
5HT flow cytometer. Approximately 5000 events (cells) were
evaluated for each sample. In all cytofluorimetric determinations,
cell debris and clumps were excluded from the analysis by gating.
Experiments were conducted by using duplicate samples for each
treatment, and each experiment was repeated at least three times.
Cells were treated with 1) doxorubicin or SFN 10 mM plus
doxorubicin for 24 h, or 2) SFN 10 mM for 24 h, washed and
treated with spermine for 24 h. After 24 h, cells were washed and
resuspended in drug-free culture medium for further 24 h.
Aliquots of 2.0610
4 cells were stained with 100 mL of Guava
Nexin Reagent (Millipore, containing ANNEXIN-V-phycoery-
thrin and 7-amino-actinomycin D) and incubated for 20 min at
room temperature in the dark. Samples were then analyzed by
flow cytometry.
Statistical analysis
All results are expressed as the mean 6 S.E. of at least three
independent experiments. Differences among treatments were
evaluated by ANOVA, followed by Bonferroni t-test, using
GraphPad InStat version 3.00 for Windows 95 (GraphPad
Software, San Diego, CA, USA). P,0.05 was considered
significant.
Results
To exclude that RNA fragmentation was an artifact associated
with cell death, we first analyzed the effect of the treatment
protocols on the cell viability. A general approach in performing
genotoxicity test is to avoid the testing of doses that decrease
viability, compared to the concurrent control cultures, by more
than 60% [24]. Treatment of Jurkat cells with different
concentrations of SFN slightly modified cell viability (Figure 1).
At the highest dose tested (30 mM), SFN decreased cell viability by
48%. Similar results were recorded for the other cell lines (data not
shown). The analysis of RNA-damaging activity was therefore
performed until the concentration of 30 mM.
Figure 1. Effect of SFN on viability of Jurkat cells. The viability
was determined immediately after treatments, as detailed in Section 2.
Data are means 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0035267.g001
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RNA-damaging effect of SFN was assessed by RIN measurement
both in cell systems and in cell-free systems. As shown in Figure 2A,
SFN did not alter RNA integrity in cell systems. The electrophe-
rogram indeed contains the marker peak at about 24S as well as 3
prominent peaks corresponding to small RNAs, 18S, and 28S
rRNA. The values of RIN reported at all the concentrations tested
were similar to that observed in untreated cultures (9.8 vs 9.9,
respectively) (Figure 2B). Similar values were observed in cultures
treated with SFN for a shorter time (6 h) (data not shown).
Interestingly, when SFN was tested in a cell-free system, it
induced a significant RNA damage (Figures 3A and B). The values
of RIN were 2.8 at 3 h and 6 h and 2.4 at 24 h. Lower
concentrations of SFN did not induce RNA damage (Figure 3B).
In the second part of the study, we analyzed the ability of SFN
to protect cells against the RNA-damaging activity of spermine,
SNAP, doxorubicin, and H2O2.
The previously performed analysis of the cytotoxic potential of
spermine, SNAP, doxorubicin, and H2O2 in Jurkat cells
demonstrated that they did not induce a decrease in cell viability
by more than 60% compared to the untreated cultures up to the
highest concentration tested (0.5 mM) (data not shown). The
viability of doxorubicin-treated cells was significantly decreased.
The only concentration exhibiting a toxicity lower than 60% was
0.01 mM (data not shown). Concentrations of 0.5 mM for
spermine, SNAP and H2O2, and 0.01 mM for doxorubicin were
then used in the experiments aimed at evaluating the protective
Figure 2. Effect of SFN on RNA integrity on Jurkat cell system. A representative electropherogram of RNA size distribution (A) and RIN values
(B) calculated after cell treatment with SFN for 24 h. Data are means 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0035267.g002
Sulforaphane Potentiates RNA Damage
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35267ability of SFN against RNA-damaging activity of the above
reported compounds.
Spermine, SNAP, H2O2, and doxorubicin induced a pro-
nounced RNA damage in Jurkat cells (Figure 4). The RIN values
were 6.360.2 for doxorubicin, 5.560.3 for spermine, 2.160.2 for
SNAP and 4.760.3 for H2O2 vs 9.660.3 for untreated cultures.
Similar values were recorded in the other cell lines and in human
lymphocytes. As an example, the RIN values were 7.0 and 5.1 for
doxorubicin, 5.2 and 5.0 for spermine, 3.6 and 4.1 for SNAP and
6.0 and 5.0 for H2O2 in HL-60 cells and T lymphocytes,
respectively.
SFN produced a significant dose-related increase in the RNA
damage induced by doxorubicin using both treatment protocols
(Figure 5). In particular, SFN reduced the RIN recorded in the
cultures treated with doxorubicin from 6.3 to values lower than 1.
For both the pre-treatment and co-treatment protocols, the
maximum reduction was obtained with SFN 30 mM, where a
decrease in the heights of 18S and 28S peaks was well evident
(Figure 5C).
Figure 3. Effect of SFN on RNA integrity on Jurkat cell-free system. A representative electropherogram of RNA size distribution (A) and RIN
values (B) after 3 h of treatment with SFN of a cell-free system. Data are means 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0035267.g003
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the RIN value induced by spermine (Figure 6A). The effect was
clearly dose-dependent with the maximum effect at the concen-
tration of SFN 30 mM, where an increase in the faint signals from
cellular RNAs with a broad range of molecular weights was
observed (Figure 6C). In the co-treatment protocol, SFN did not
affect the RNA damage induced by spermine (Figure 6B).
The effect of SFN was negligible or null against the RNA
damaging properties of SNAP and H2O2. For SNAP, only a slight
decrease of RIN was observed in the pre-treatment protocol and at
the highest concentration of SFN (Figures 7A and C). The values
of RIN recorded in cells co-treated with SNAP plus SFN and in
both treatment protocols for H2O2 were similar to those recorded
in untreated cells (Figures 7B and 8).
Figure 4. Effect of different xenobiotics on RNA integrity in Jurkat cells. Electropherograms of RNA size distribution recorded in untreated
cultures and after 24 h of treatment with doxorubicin, spermine, SNAP or H2O2. The data are representative of three different experiments with
similar results.
doi:10.1371/journal.pone.0035267.g004
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SFN on doxorubicin- and spermine-induced RNA damage, the
same experiments were performed using different cell lines,
namely HL-60 and KU812F. Results shown in Figure 9 indicate
that SFN 30 mM was capable of potentiating the RNA damage
induced by doxorubicin and spermine in HL-60 cells. No effect of
SFN on the RNA damage induced by SNAP and H2O2 was
recorded in the same cell line. Similar results were observed in
KU812F cells and in normal T lymphocytes (data not shown), thus
demonstrating a lack of cell-type specificity for these effects.
To test the possibility that the ability of SFN to enhance the
RNA-damaging properties of doxorubicin and spermine was an
artifact associated with a cytotoxic effect, we immediately analyzed
the effect of the treatment protocols on Jurkat cell viability. No
reduction of cell viability was observed after treatment with SFN
plus doxorubicin or SFN plus spermine (data not shown).
On the whole, our results indicated a general inability of SFN to
protect RNA from the insult caused by the four chemicals.
Because of SFN’s capacity to potentiate the RNA-damaging
properties of doxorubicin and spermine, we performed a series of
experiments in order to elucidate its mechanism of action in Jurkat
cells.
We first analyzed the ability of SFN to induce thioredoxin
reductase activity. Treatment of cells with SFN 10 mM for 24 h
significantly up-regulated thioredoxin reductase specific activity
(Figure 10).
To know whether the effect of SFN on increasing the spermine-
induced RNA damage was dependent on the increased formation
of ROS, we determined the levels of ROS in cultures treated with
SFN, spermine or SFN plus spermine (pre-treatment protocol).
The formation of DCF was determined and quantified by means
of a multilabel microplate reader. Results depicted in Figure 10A
indicate that SFN (10 mM for 3 h) and spermine (0.5 mM for 3 h)
caused the conversion of DCFH into its fluorescent by-product, a
process which reflects the formation of ROS. Treatment of cells
with SFN (10 mM for 3 h) plus spermine (0.5 mM for 3 h) greatly
increased the formation of ROS. ROS formation was also
investigated in cells treated with the above reported compounds
Figure 5. Effect of doxorubicin plus SFN on RNA damage in Jurkat cells. RIN values calculated after pre-treatment (A) or co-treatment (B) of
cells with SFN plus doxorubicin and representative electropherograms of RNA size distribution after treatment with doxorubicin plus SFN (C). Data are
means 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0035267.g005
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were similar to those detected in untreated cells (Figure 11B).
GSH depletion affects the antioxidant capacity of the coupled
glutathione peroxidase–glutathione S-transferases system sensitiz-
ing target cells to oxidative stress. As shown in Figure 12A, short
treatment with both SFN and spermine decreased cellular
glutathione levels. The effect was significantly more marked in
the cells treated with SFN plus spermine. However, the GSH-
depletion induced by SFN was transient, as indicated by the levels
of GSH similar to untreated cultures reported after 24 h of
treatment (Figure 12B).
Finally, we analyzed the impact of RNA damage induction in
the context of cell survival. In particular, the last part of our study
was addressed to the study of the consequences and cellular
handling of the RNA damage induced by doxorubicin and
spermine alone and in combination with SFN. Flow cytometric
analysis at 24 h post-spermine or -doxorubicin treatment showed
that a significant proportion of cells underwent apoptosis,
suggesting that this latter might be a relevant type of cell death
in this exposure paradigm (Figure 13). To investigate whether SFN
could increase the cytotoxicity of spermine and doxorubicin, cells
were treated with a combination of spermine or doxorubicin plus
SFN. The fraction of apoptotic cells induced after treatment with
spermine or doxorubicin and pre- or co-treatment with SFN,
respectively, was significantly greater than the fraction of apoptosis
induced by exposure to spermine or doxorubicin alone (Figure 13).
Discussion
In the present study, we clearly demonstrated that SFN did not
alter RNA integrity in different cell systems. This is quite
surprisingly because (1) our study also indicated that 3 h-treatment
of cells with SFN was able to elicit intracellular ROS and different
in vitro experiments reported that total RNA is susceptible to free
Figure 6. Effect of spermine plus SFN on RNA damage in Jurkat cells. RIN values calculated after pre-treatment (A) or co-treatment (B) of
cells with SFN plus spermine and representative electropherograms of RNA size distribution after treatment with spermine plus SFN (C). Data are
means 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0035267.g006
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absence of protective histones [13,14,25]; (2) we previously
demonstrated that SFN is able to induce DNA single strand
breaks [9]. The reasons for these apparent conflicting results can
be complex and, due to the still poor comprehension of the
mechanisms leading to RNA damage, certainly requires ad hoc
studies. However, Martinet et al. indicated that if the quantity of
total RNA per cell is in the order of 10 pg, the intracellular free
radical production needed to destroy the intracellular RNA
content will be approximately 50 nM [14]. In our experiments,
the concentrations of SFN used are lower than those used for the
other compounds. They could be not enough to generate a level of
ROS able to induce RNA damage in a cell system detectable by
our capillary electrophoretic analysis. In addition, we reported that
SFN-induced DNA damage depends entirely on intramitochon-
drial formation of ROS [9]: therefore, although it is a mere
speculation deserving specific investigation, the site of ROS
generation (i.e. mitochondrial vs. cytosolic or extracellular) might
lie at the cross between the tendency of ROS to preferentially
damage DNA, RNA or both. Such a hypothesis (i.e. that, unlike
mitochondrially generated ROS, those formed extracellularly and
within cytoplasm damage RNA) is indirectly strengthened by the
finding that spermine and H2O2, which generate ROS at the
extracellular and cytoplasmic level, do promote RNA damage (see
below).
It is of worth to note that the treatment of RNA extracted from
Jurkat cells with SFN 30 mM (a cell-free system) induced a
significant RNA damage. These results cast light on the apparently
unexpected inability of SFN to induce RNA damage in a cell
system. Isothiocyanates compounds are normally unstable towards
nucleophiles. Thus, it is conceivable that SFN interact with
multiple biological nucleophiles such as cysteine in proteins and
the tripeptide glutathione in a cell system [26,27]. Modification of
proteins is actually recognized as a key mechanism underlying the
biological activity of isothiocyanates. In vitro experiments advocate
the possibility of interaction between isothiocyanates and proteins
having active thiol groups, such as thioredoxin and JNK
phosphatase [28,29], NOX2 [30], adenine nucleotide translocase
[31], CYP isozyme [32], histone deacetylase [33], a transient
receptor potential family of ion channels [34]. On the contrary,
the only biological nucleophile available for SFN in our cell-free
system is RNA. This means that, due to the high reactivity of SFN
with cellular targets different from RNA, the amount of SFN able
to react with RNA is low in a cell system and not enough to
Figure 7. Effect of SNAP plus SFN on RNA damage in Jurkat cells. RIN values calculated after pre-treatment (A) or co-treatment (B) of cells
with SFN plus SNAP and representative electropherograms of RNA size distribution after treatment with SNAP plus SFN (C). Data are means 6 SEM of
three independent experiments.
doi:10.1371/journal.pone.0035267.g007
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electrophoretic analysis.
The levels of ROS induced by SFN in Jurkat cells strongly
decreased after 24 h of treatment with SFN. The dual effect of
SFN on ROS levels can be associated with the dual effect of SFN
on GSH levels. Over the last decade, a number of studies have
shown that SFN is taken into cells almost entirely by conjugation
with cellular GSH and is exported from the cell as a GSH
conjugate [35,36]. This can cause a decrease in cellular GSH, as
we demonstrated in our cell system treated with SFN for 3 h. Later
(24 h), SFN increases GSH levels by upregulating GSH synthe-
sizing pathways mediated through c-glutamylcysteine synthetase,
the rate-limiting step in GSH synthesis. Thus, SFN may cause an
immediate oxidizing effect, followed by an enhanced GSH
synthesis and a return to a lower redox state [1].
Treatment of Jurkat cells with H2O2, SNAP, doxorubicin or
spermine for 24 h induced RNA damage in all the cell lines tested
and in normal human T lymphocytes. Under the selected
exposure conditions, they did not alter cell viability by more than
60% compared to the concurrent control cultures. Since indirect
mechanisms related to cytotoxicity may lead to enhanced RNA
fragmentation, this finding implies that RNA damage induced by
the above reported compounds is not the result of aspecific death-
related events, but rather is likely to depend on their direct action
on RNA.
In this context, it is important to note that changes of RNA
size/level distribution observed in the RNA electropherograms do
not necessarily indicate potential damages by a xenobiotic. Indeed
– although the inclusion of RNase-free reagents and RNase
inhibitors prevent RNA from damage by endogenous and
exogenous RNAase – some processes such as RNA synthesis
Figure 8. Effect of H2O2 plus SFN on RNA damage in Jurkat cells. RIN values calculated after pre-treatment (A) or co-treatment (B) of cells
with SFN plus H2O2 and representative electropherograms of RNA size distribution after treatment with H2O2 plus SFN (C). Data are means 6 SEM of
three independent experiments.
doi:10.1371/journal.pone.0035267.g008
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RNA electropherograms. However, these are common problems
with one of the most used genotoxicity assay, the Comet test. In
the Comet assay, increased DNA migration is associated with
increased levels of DNA damage such as strand breaks and alkali-
labile sites. Furthermore, increased DNA migration may also
derive from the presence of single-strand breaks associated with
incomplete excision repair sites. On the other hand, a decrease in
DNA migration can result from the ability of crosslinks to stabilize
DNA molecule [37].
SFN did not affect the RNA damage induced by H2O2. This
latter finding is not in keeping with our previous data, which
reported that SFN was capable to afford protection against DNA
damage induced by H2O2 [19]. These apparent contradictory
results might largely depend on the different treatment conditions
used in the two studies. Indeed a high H2O2 concentration
(0.5 mM vs. 0.1 mM H2O2 in Ref. 19) was used throughout the
present study. Such a higher dose of H2O2, selected to induce a
significant RNA damage, is likely to yield a level of ROS that
stoichiometrically overwhelms the scavenging potential of SFN.
Also in support of our hypothesis is the inability of SFN at all
concentrations studied (up to 100 mM) to scavenge H2O2, used at
a very high concentration (7.5 mM), reported in a recent study
[38].
Under our experimental conditions, the RNA damage induced
by SNAP was not affected by SFN. SNAP exerts its toxic activity
through the production of reactive nitrogen species [39]. An aspect
worth considering is that SNAP could generate radicals that are
not SFN-sensitive. Other experiments are necessary for supporting
this hypothesis.
Pre-treatment and co-treatment with SFN markedly enhanced
the RNA-damaging activities of doxorubicin, one of the most
effective anticancer drugs ever developed. Doxorubicin undergoes
bioreductive activation by redox-cycling reactions. One-electron
addition to the quinone moiety of doxorubicin is associated with
the formation of a semiquinone. The latter quickly regenerates its
parent quinone by reducing ground state oxygen to ROS, such as
superoxide anion and its dismutation product, hydrogen peroxide.
Toxicity of doxorubicin rests with the DNA intercalation of the
semiquinone radical. The superoxide generated in this redox-
cycling process induces additional, qualitatively different, DNA
lesions [40].
The biological role of thioredoxin reductase is to transfer
reducing equivalents from NADPH to various oxidized substrates.
Thioredoxin reductase, together with its substrate thioredoxin,
forms a redox system, which plays multiple roles and acts on
different substrates such as lipoic acid, lipid hydroperoxides,
Figure 9. Effect of SFN 30 mM on RNA damage induced by
doxorubicin, spermine, SNAP and H2O2 in HL-60 cells. RIN
values were calculated after pre-treatment of cells with SFN for 24 h
(6 h for H2O2). Data are means 6 SEM of three independent
experiments.
doi:10.1371/journal.pone.0035267.g009
Figure 10. Effect of SFN on thioredoxin reductase activity in
Jurkat cells. Effects of SFN (10 mM) on thioredoxin reductase activity
after 3 h (A) or 24 h (B) of treatment. Data are means 6 SEM of three
independent experiments with triplicate dishes.
doi:10.1371/journal.pone.0035267.g010
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thioredoxin system protects cells and tissues against oxidative
stress. Thioredoxin is a scavenger of hydroxyl radical and a
quencher of singlet oxygen. However, it does not scavenge
superoxide anion [42]. Previous studies have shown that
doxorubicin is a substrate for mammalian thioredoxin reductase.
In particular, Ravi and Das demonstrated that the E. coli
thioredoxin system enhanced the redox-cycling of anthracyclines
and increased the generation of superoxide anion [43].
In keeping with a previous study [44], we demonstrated that
SFN induced the thioredoxin reductase activity. The increase in
thioredoxin reductase activity by SFN was observed at 24 h and at
a time-point before the 24 h, i.e. 3 h. This suggests that the
increase in thioredoxin reductase activity by SFN could be the key
mechanism involved in the enhancement of doxorubicin-induced
RNA damage by SFN in both treatment protocols. Depletion of
intracellular GSH caused by SFN, to form the SFN-SG conjugate,
is a fundamental step in the modulation of thioredoxin reductase
expression [43]. When cells were treated with SFN for 3 h, we
observed an initial decrease in cellular GSH levels. A recovery of
intracellular GSH levels was reported after a longer treatment
(24 h). Interestingly, the thioredoxin reductase activity was still
elevated at 24 h of treatment with SFN. Hence, possibly what SFN
may be promoting is increasing the cellular damage of doxorubicin
by modulating its bioreductive activation. A depletion of GSH
Figure 11. Effect of SFN and spermine on ROS levels in Jurkat
cells. Effect of SFN, spermine and SFN plus spermine on ROS levels
determined by microplate fluorescence reader. Cells were treated for
3 h (A) or 24 h (B) with SFN (10 mM), spermine (0.5 mM) or SFN
(10 mM)+spermine (0.5 mM) to analyze the oxidation state of the cell by
using DCFH-DA as fluorogenic probe. Results are expressed as
percentages of control (untreated cells) and are means 6 SEM of four
independent experiments with triplicate dishes.
doi:10.1371/journal.pone.0035267.g011
Figure 12. Effect of SFN and spermine on glutathione levels in
Jurkat cells. Effect of SFN, spermine and SFN plus spermine on
glutathione level determined by microplate fluorescence reader. Cells
were treated for 3 h (A) or 24 h (B) with SFN (10 mM), spermine
(0.5 mM) or SFN (10 mM)+spermine (0.5 mM). Results are means 6 SEM
of four independent experiments with triplicate dishes.
doi:10.1371/journal.pone.0035267.g012
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activation.
The polyamine spermine has an important role in the viability
and propagation of most cells. However, many studies reported
that spermine is also the source of cytotoxic metabolites Amine
oxidase in fetal calf serum catalyses the oxidative deamination of
spermine and produces aminodialdehyde, H2O2, and ammonia.
Aminodialdehyde produced during the oxidation of spermine
subsequently undergoes spontaneous b-elimination to form
acrolein [44]. Notably, the degree of cytotoxicity of spermine is
nearly parallel with the amount of acrolein produced and
spermine toxicity is prevented by aldehyde dehydrogenase, which
eliminates these reactive species and prevents the formation of
acrolein [45].
In our experimental settings, spermine induced a significant
RNA damage, which was clearly potentiated by pre-treatment
with SFN, while it remained unchanged in the co-treatment
protocol.
Interestingly, the RNA-damaging effects observed for spermine
might directly depend on the formation of ROS promoted by
spermine metabolism. Therefore, we performed a set of experi-
ments aimed at determining whether and how much spermine
gives rise to ROS under the treatment conditions adopted for
evaluating RNA damage. Here the formation of ROS was directly
monitored in experiments involving the sensitive probe DCFH,
which – upon oxidation – is converted to its fluorescent derivative,
DCF. Surprisingly, we did not observe an increase in the levels of
ROS after 24 h-treatment with spermine or SFN plus spermine.
However, when we analyzed the levels of ROS after 3 h of
treatment, we recorded a significant increase in the ROS levels
both in cells treated with spermine and in cells treated with the
association. The highest levels of ROS observed after treatment
with spermine easily explain their ability to attack RNA and
initiate RNA damage. Despite the lack of a ROS increase after
24 h of treatment with spermine, we recorded RNA damage after
24 h of treatment with spermine. In this context, it is important to
note that Sharmin et al. [45] demonstrated that the stability of
acrolein in the presence of fetal calf serum is strongly decreased
with time. The remaining acrolein produced from spermine
decreased from about 60% to about 10% in 90 min. This
observation can easily explain the low levels of ROS we observed
after 24 h treatment with spermine. The persistence of RNA
damage can be due to the fact that, although cells may have
multiple mechanisms of dealing with RNA damage [46–48],
glycosylases - able to remove oxidatively damaged bases - have not
yet been identified in RNA. Along this line, a previous attempt to
induce chain breaks at RNA through the use of 7,8-dihydro-8-oxo-
29-deoxyguanosine specific glycosylase failed [49]. Our results
strongly suggested that spermine induced RNA damage through
the production of ROS in the first hours of treatment and that
RNA damage persisted due to the lack of specific repair systems.
This hypothesis was confirmed by an additional analysis of RNA
integrity after 6 h of cell treatment with spermine, where a
decrease in the RIN value was detected compared to the
concurrent control cultures (data not shown).
As regards the effect of SFN on the RNA damage induced by
spermine, pre-treatment with SFN markedly enhanced the RNA-
damaging potential of spermine. In an attempt to delineate the
mechanism involved in this effect, we decided to investigate the
levels of ROS induced by SFN plus spermine at 3 h of treatment.
We recorded a statistically significant increase in the ROS level
after the combined treatment (pre-treatment with SFN for 3 h,
followed by treatment with spermine for 3 h). The increase in
ROS production caused by SFN plus spermine was additive. This
is not unexpected because other papers have shown that SFN
causes a transient increase in ROS production [50]. SFN is also
able to inhibit and reduce the expression of aldehyde dehydro-
genase [51,52], an enzyme known to prevent and/or eliminate the
aldehydes produced during the oxidation of spermine [45].
However, a 3 h-treatment with SFN is too short to lead to
enzyme induction/downregulation and it is unlikely that enzyme
downregulation is involved in the enhancement of RNA-damaging
potential of spermine by SFN.
As to the co-treatment conditions, SFN did not affect the RNA-
damaging activity of spermine. Recent studies reported that
spermine [53] and SFN [36] exposure reduced intracellular GSH
levels. Data presented here lend further support to this latter
notion and extend its toxicological meaning. Our results indeed
demonstrated that spermine and SFN reduced intracellular GSH
levels and that the decrease in the GSH levels was more
pronounced in the cultures co-treated with SFN plus spermine.
As reported above, GSH represents the major driving force for
SFN accumulation by undergoing conjugation with the entering
SFN [35]. Moreover, Zhang demonstrated that altering cellular
GSH levels results in proportional changes in cellular SFN uptake
and accumulation [36]. Along this line, the marked reduction of
GSH evidenced in the cells co-treated with spermine plus SFN can
hamper the uptake of SFN by GSH thereby strongly reducing or
almost suppressing the intracellular levels of SFN. In this
condition, SFN could not affect spermine toxicity.
Notably, the effects of SFN on the RNA damaging activity of
doxorubicin, spermine, SNAP and H2O2 lacked cell-type
specificity, since it could be observed in HL-60, KU812F and
normal T cells.
As to the cytotoxic relevance of the events described in this
study, we found that the treatment of cultures with spermine or
doxorubicin, both alone and more strongly in combination with
SFN, induced apoptosis. However, it is hard to distinguish
between the relative importances of RNA damage as compared
to other possible toxic effects promoted by the above reported
chemicals. A lot of studies reported proapoptotic activity of SFN in
Figure 13. Induction of apoptosis by SFN plus spermine or
doxorubicin in Jurkat cells. Fraction of apoptotic cells following pre-
or co-treatment conducted with SFN (10 mM) and spermine (0.5 mM) or
doxorubicin (0.01 mM), respectively. Results are means 6 SEM of four
independent experiments with triplicate dishes.
doi:10.1371/journal.pone.0035267.g013
Sulforaphane Potentiates RNA Damage
PLoS ONE | www.plosone.org 13 April 2012 | Volume 7 | Issue 4 | e35267many experimental models [2,4,9,54]. In our study, SFN did not
induce RNA damage. Thus it is conceivable that the presence of
RNA damage might simply concur to the overall toxic response
induced by a chemical agent in targeted cells. Various cell
signaling network models indicate that partial inhibition of a
number of targets is more effective than the complete inhibition of
a single target in many areas of medicine [55]. In this light, our
data also pave the way to an appraisal of the contribution of
spermine- or doxorubicin-induced RNA damage to the net
cytotoxic response of intoxicated cells.
In conclusion, we demonstrated that RNA did not represent a
target for the toxic action of SFN. Furthermore, SFN was unable
to protect cells from RNA insult induced by different toxic agents.
The induction of RNA damage still represents a maturing
approach and its true potential remains to be defined and studied.
As an example, an open question emerged from the present study
which would deserve specific studies deals with the problem of
RNA differential susceptibility to ROS arising from selected
subcellular compartments. However, it is worth noting that RNA
is being investigated as a potential target for new anticancer
agents: the induction of damage to RNA is clearly an interesting
and potentially useful therapeutic approach, as demonstrated by
successful pre-clinical and clinical trials [56–59]. In this context,
the induction of RNA damage may represent an additional target
of doxorubicin. The ability of SFN, at nutritionally attainable
concentrations, to enhance RNA damage and cytotoxicity
deserves consideration as an additional mechanism potentially
responsible for the potentiating effects of SFN associated with
conventional anticancer drugs, such as doxorubicin. Notably,
polyamine analogues have demonstrated interesting pre-clinical
results in different model systems of cancer, but their clinical utility
has been limited by apparent toxicity [60]. The use of polyamines
in association with SFN, along with reducing the dosage of
polyamines, may enhance its anticancer efficacy.
Author Contributions
Conceived and designed the experiments: CF PS. Performed the
experiments: ML ET LF. Analyzed the data: CF ML. Wrote the paper:
CF PS PH GCF.
References
1. Zhang Y, Talalay P, Cho GC, Posner GH (1992) A major inducer of
anticarcinogenic protective enzymes from broccoli: isolation and elucidation of
structure. Proc Natl Acad Sci U S A 89: 2399–2403.
2. Clarke JD, Dashwood RH, Ho E (2008) Multi-targeted prevention of cancer by
sulforaphane. Cancer Lett 269: 291–304.
3. Fahey JW, Zhang Y, Talalay P (1997) Broccoli sprouts: an exceptionally rich
source of inducers of enzymes that protect against chemical carcinogens. Proc
Natl Acad Sci U S A 94: 10367–10372.
4. Fimognari C, Hrelia P (2007) Sulforaphane as a promising molecule for fighting
cancer. Mutat Res 635: 90–104.
5. Yoshida K (2008) Nuclear trafficking of pro-apoptotic kinases in response to
DNA damage. Trends Mol Med 14: 305–313.
6. Cho SD, Li G, Hu H, Jiang C, Kang KS, et al. (2005) Involvement of c-Jun N-
terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by
sulforaphane in DU145 prostate cancer cells. Nutr Cancer 52: 213–224.
7. Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, et al. (2005)
Sulforaphane-induced cell death in human prostate cancer cells is initiated by
reactive oxygen species. J Biol Chem 280: 19911–19924.
8. Kim H, Kim EH, Eom YW, Kim WH, Kwon TK, et al. (2006) Sulforaphane
sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-
resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen
species-mediated up-regulation of DR5, Cancer Res 66: 1740–1750.
9. Sestili P, Paolillo M, Lenzi M, Colombo E, Vallorani L, et al. (2010)
Sulforaphane induces DNA single strand breaks in cultured human cells. Mutat
Res 689: 65–73.
10. Fimognari C, Berti F, Iori R, Cantelli-Forti G, Hrelia P (2005) Micronucleus
formation and induction of apoptosis by different isothiocyanates and a mixture
of isothiocyanates in human lymphocyte cultures. Mutat Res 582: 1–10.
11. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, et al. (1999) RNA
oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease.
J Neurosci 19: 1959–1964.
12. Baltimore D (2001) Our genome unveiled. Nature 409: 814–816.
13. Martinet W, De Meyer GRY, Herman AG, Kockx MM (2004) Reactive oxygen
species induce RNA damage in human atherosclerosis. Eur J Clin Inv 34:
323–327.
14. Martinet W, De Meyer GRY, Herman AG, Kockx MM (2005) RNA damage in
human atherosclerosis Pathophysiological significance and implications for gene
expression studies., RNA Biol 2: e4–e7.
15. Nunomura A, Honda K, Takeda A, Hirai K, Zhu X, et al. (2006) Oxidative
damage to RNA in neurodegenerative diseases. J Biomed Biotechnol 2006: 1–6.
16. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, et al. (2006)
Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol
65: 631–641.
17. Nunomura A, Moreira PI, Takeda A, Smith MA, Perry G (2007) Oxidative
RNA damage and neurodegeneration. Curr Med Chem 14: 2968–2975.
18. Barcelo S, Gardiner JM, Gescher A, Chipman JK (1996) CYP2E1-mediated
mechanism of anti-genotoxicity of the broccoli constituent sulforaphane.
Carcinogenesis 17: 277–282.
19. Fimognari C, Berti F, Cantelli-Forti G, Hrelia P (2005) Effect of sulforaphane on
micronucleus induction in cultured human lymphocytes by four different
mutagens. Environ Mol Mutagen 46: 260–267.
20. Fimognari C, Sestili P, Lenzi M, Cantelli-Forti G, Hrelia P (2009) Protective
effect of creatine against RNA damage. Mutat Res 670: 59–67.
21. Fimognari C, Sestili P, Lenzi M, Bucchini G, Cantelli-Forti G, et al. (2008) RNA
as a new target for toxic and protective agents. Mutat Res 648: 15–22.
22. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The
RIN: an RNA integrity number for assigning integrity values to RNA
measurements. BMC Mol Biol 7: 3.
23. Smith JA, Weidemann MJ (1993) Further characterization of the neutrophil
oxidative burst by flow cytometry. J Immunol Methods 162: 261–268.
24. Kirsch-Volders M, Sofuni T, Albertini S, Eastmond D, Fenech M, et al. (2003)
Report from the in vitro micronucleus assay working group. Mutat Res 540:
153–163.
25. Bre ´geon D, Sarasin A (2005) Hypothetical role of RNA damage avoidance in
preventing human disease. Mutat Res 577: 293–302.
26. Drobnica L, Kristian P, Augustin J (1977) The chemistry of the NCS group. In:
Patai S, ed. Cyanates and their thio derivatives. New York: Wiley. pp
1003–1221.
27. Zhang Y (2000) Role of glutathione in the accumulation of anticarcinogenic
isothiocyanates and their glutathione conjugates by murine hepatoma cells.
Carcinogenesis 21: 1175–1182.
28. Hu Y, Urig S, Koncarevic S, Wu X, Fischer M, et al. (2007) Glutathione- and
thioredoxin-related enzymes are modulated by sulfur-containing chemopreven-
tive agents. Biol Chem 388: 1069–1081.
29. Chen YR, Han J, Kori R, Kong AN, Tan TH (2002) Phenylethyl isothiocyanate
induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-
terminal kinase. J Biol Chem 277: 39334–39342.
30. Miyoshi N, Takabayashi S, Osawa T, Nakamura Y (2004) Benzyl isothiocyanate
inhibits excessive superoxide generation in inflammatory leukocytes: implication
for prevention against inflammation-related carcinogenesis. Carcinogenesis 25:
567–575.
31. Kawakami M, Harada N, Hiratsuka M, Kawai K, Nakamura Y (2005) Dietary
isothiocyanates modify mitochondrial functions through their electrophilic
reaction. Biosci Biotechnol Biochem 69: 2439–2444.
32. Conaway CC, Krzeminski J, Amin S, Chung FL (2001) Decomposition rates of
isothiocyanate conjugates determine their activity as inhibitors of cytochrome
p450 enzymes. Chem Res Toxicol 14: 1170–1176.
33. Wang LG, Chiao JW (2010) Prostate cancer chemopreventive activity of
phenethyl isothiocyanate through epigenetic regulation (review). Int J Oncol 37:
533–539.
34. Hinman A, Chuang HH, Bautista DM, Julius D (2006) TRP channel activation
by reversible covalent modification. Proc Natl Acad Sci USA 103: 19564–19568.
35. Zhang Y, Callaway EC (2002) High cellular accumulation of sulforaphane, a
dietary anticarcinogen, is followed by rapid transporter-mediated export as a
glutathione conjugate. Biochem J 364: 301–307.
36. Zhang Y (2001) Molecular mechanisms of rapid cellular accumulation of
anticarcinogenic isothiocyanates. Carcinogenesis 22: 425–431.
37. Witte I, Plappert U, de Wall H, Hartmann A (2007) Genetic toxicity assessment:
employing the best science for human safety evaluation part III: the comet assay
as an alternative to in vitro clastogenicity tests for early drug candidate selection.
Toxicol Sci 97: 21–26.
38. Gaona-Gaona L, Molina-Jijo ´n E, Tapia E, Zazueta C, Herna ´ndez-Pando R, et
al. (2011) Protective effect of sulforaphane pretreatment against cisplatin-
induced liver and mitochondrial oxidant damage in rats. Toxicology 286: 20–27.
39. Oliveira CJR, Curcio MF, Moraes MS, Tsujita M, Travassos LR (2008) The
low molecular weight S-nitrosothiol, S-nitroso-N-acetylpenicillamine, promotes
cell cycle progression in rabbit aortic endothelial cells. Nitric Oxide 18: 241–255.
Sulforaphane Potentiates RNA Damage
PLoS ONE | www.plosone.org 14 April 2012 | Volume 7 | Issue 4 | e3526740. Ravi D, Das KC (2004) Redox-cycling of anthracyclines by thioredoxin system
increased superoxide generation and DNA damage. Cancer Chemother
Pharmacol 54: 449–458.
41. Mustacich D, Powis G (2000) Thioredoxin reductase. Biochem J 346: 1–8.
42. Das KC, Das CK (2000) Thioredoxin, a singlet oxygen quencher and hydroxyl
radical scavenger: redox independent functions. Biochem Biophys Res Commun
277: 443–447.
43. Zhang J, S ˇvehlı ´kova ´ V, Bao Y, Forbes Howie A, Beckett GJ, et al. (2003) Sinergy
between sulforaphane and selenium in the induction of thioredoxin reductase 1
requires both transcriptional and translational modulation. Carcinogenesis 24:
497–503.
44. Houen G, Bock K, Jensen AL (1994) HPLC and NMR investigation of the
serum amine oxidase catalyzed oxidation of polyamines. Acta Chem Scand 48:
52–60.
45. Sharmin S, Sakata K, Kashiwagi K, Ueda S, Iwasaki S, et al. (2001) Polyamine
cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys
Res Commun 282: 228–235.
46. Drablos F, Feyzi E, Aas PA, Va ˚gbø CB, Kavli B, et al. (2004) Alkylation damage
in DNA and RNA, Repair mechanisms and medical significance. DNA Repair
3: 1389–1407.
47. Aas PA, Otterlei M, Falnes PO, Va ˚gbø CB, Skorpen F, et al. (2003) Human and
bacterial oxidative demethylases repair alkylation damage in both RNA and
DNA. Nature 421: 859–863.
48. Bellacosa A, Moss EG (2003) RNA repair: damage control. Curr Biol 13:
R4824.
49. Rhee Y, Valentine MR, Termini J (1995) Oxidative base damage in RNA
detected by reverse transcriptase. Nucleic Acids Res 23: 3275–3282.
50. Antosiewicz J, Ziolkowski W, Kar S, Powolny AA, Singh SV (2008) Role of
reactive oxygen intermediates in cellular responses to dietary cancer chemopre-
ventive agents. Planta Med 74: 1570–1579.
51. Kallifatidis G, Labsch S, Rausch V, Mattern J, Gladkich J, et al. (2011)
Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells
of pancreas and prostate. Mol Ther 19: 188–195.
52. Rausch V, Liu L, Kallifatidis G, Baumann B, Mattern J, et al. (2010) Synergistic
activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell
characteristics. Cancer Res 70: 5004–5013.
53. Sinha-Hikim I, Shen R, Paul Lee WN, Crum A, Vaziri ND, et al. (2010) Effects
of a novel cystine-based glutathione precursor on oxidative stress in vascular
smooth muscle cells. Am J Physiol Cell Physiol 299: C638–642.
54. Cheung KL, Kong AN (2010) Molecular targets of dietary phenethyl
isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 12:
87–97.
55. Rodon J, Perez J, Kurzrock R (2010) Combining targeted therapies: practical
issues to consider at the bench and bedside. Oncologist 15: 37–50.
56. Iordanov MS, Ryabinina OP, Wong J, Dinh TH, Newton DL, et al. (2000)
Molecular determinants of apoptosis induced by the cytotoxic ribonuclease
onconase: evidence for cytotoxic mechanisms different from inhibition of protein
synthesis. Cancer Res 60: 1983–1994.
57. Tafech A, Bassett T, Sparanese D, Lee CH (2006) Destroying RNA as a
therapeutic approach. Curr Med Chem13: 863–881.
58. Arnold U, Ulbrich-Hofmann R (2006) Natural and engineered ribonucleases as
potential cancer therapeutics. Biotechnol Lett 28: 1615–1622.
59. Schulenburg C, Ardelt B, Ardelt W, Arnold U, Shogen K, et al. (2007) The
interdependence between catalytic activity, conformational stability, and
cytotoxicity of onconase. Cancer Biol Ther 6: 1233–1239.
60. Hacker A, Marton LJ, Sobolewski M, Casero RA, Jr. (2008) In vitro and in vivo
effects of the conformationally restricted polyamine analogue CGC-11047 on
small cell and non-small cell lung cancer cells. Cancer Chemother Pharmacol
63: 45–53.
Sulforaphane Potentiates RNA Damage
PLoS ONE | www.plosone.org 15 April 2012 | Volume 7 | Issue 4 | e35267